Prevalence of Significant Liver Fibrosis and Inflammation in Chronic HBV Infected Patients in Grey Zone
Clinical trial NCT05483049 · UNKNOWN
Trial details
- NCT number
- NCT05483049
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-01
- Primary completion
- 2023-03-31
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.